Pure Global

LiRAS for LiPA HLA - Taiwan Registration 064d68cbec26a09925da22a963b1e7f2

Access comprehensive regulatory information for LiRAS for LiPA HLA in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 064d68cbec26a09925da22a963b1e7f2 and manufactured by FUJIREBIO EUROPE N.V.. The authorized representative in Taiwan is Taiwan Fu Pharmaceutical Co., Ltd.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
064d68cbec26a09925da22a963b1e7f2
Registration Details
Taiwan FDA Registration: 064d68cbec26a09925da22a963b1e7f2
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

LiRAS for LiPA HLA
TW: ็ซ‹ๅธ•ไบบ้กž็™ฝ่ก€็ƒๆŠ—ๅŽŸๅˆ†ๆž่ปŸ้ซ”
Risk Class 2
MD
Cancelled

Registration Details

064d68cbec26a09925da22a963b1e7f2

Ministry of Health Medical Device Import No. 028424

DHA05602842409

Company Information

Belgium

Product Details

B Hematology and pathology devices

B0001 Human leukocyte antigen segmentation board

Imported from abroad

Dates and Status

May 13, 2016

May 13, 2026

Oct 28, 2022

Cancellation Information

Logged out

ๅ…ฌๅธๆญ‡ๆฅญ